据我所知，全球前25家最大制药企业的代表在今年达沃斯世界经济论坛年会即将举行之际见面讨论抗菌素耐药性评估，并同意就此问题保持进一步接触。
Representatives of the 25 largest pharmaceutical firms, I am told, met on the fringes of the World Economic Forum’s annual meeting in Davos this year to discuss AMR, agreeing to remain engaged on the issue.